Skip to content

US research shows that HPV vaccination could prevent pre-cancerous anal cell changes in HIV-positive gay men

Liver cancer has a more aggressive disease course in HIV-positive people co-infected with viral hepatitis

Brivanib fails to match sorafenib for liver cancer, but tivantinib looks promising

Philip Johnson from the University of Birmingham.  © Liz Highleyman / hivandhepatitis.com

Nucleoside analogues reduce hepatitis B liver cancer risk

Dramatic increase in incidence of liver cancer in HIV-positive people with viral hepatitis

Antiviral treatment reduces risk of liver cancer in people with hepatitis C-related cirrhosis and fibrosis

Cidofovir cream an effective and safe treatment for high-grade pre-cancerous HPV lesions

Starting HIV treatment reduces the risk of serious non-AIDS-related diseases

Progression of anal neoplasia is common among gay men with HIV

Carmen Hidalgo © Liz Highleyman / hivandhepatitis.com